Rocket Pharmaceuticals Inc (RCKT)
22.34
-0.49
(-2.15%)
USD |
NASDAQ |
May 21, 16:00
22.34
0.00 (0.00%)
After-Hours: 16:40
Rocket Pharmaceuticals Cash from Operations (Quarterly): -56.86M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -56.86M |
December 31, 2023 | -29.34M |
September 30, 2023 | -57.15M |
June 30, 2023 | -50.87M |
March 31, 2023 | -57.56M |
December 31, 2022 | -56.02M |
September 30, 2022 | -43.86M |
June 30, 2022 | -39.04M |
March 31, 2022 | -39.22M |
December 31, 2021 | -30.94M |
September 30, 2021 | -27.41M |
June 30, 2021 | -38.53M |
March 31, 2021 | -24.28M |
December 31, 2020 | -13.11M |
September 30, 2020 | -17.25M |
June 30, 2020 | -22.03M |
March 31, 2020 | -22.24M |
December 31, 2019 | -19.73M |
September 30, 2019 | -10.85M |
June 30, 2019 | -18.10M |
March 31, 2019 | -15.98M |
Date | Value |
---|---|
December 31, 2018 | -20.81M |
September 30, 2018 | -11.64M |
June 30, 2018 | -9.738M |
March 31, 2018 | -11.60M |
December 31, 2017 | -16.14M |
September 30, 2017 | -4.094M |
June 30, 2017 | -2.156M |
March 31, 2017 | -3.723M |
December 31, 2016 | -11.14M |
September 30, 2016 | -9.132M |
June 30, 2016 | -8.003M |
March 31, 2016 | -8.993M |
December 31, 2015 | -7.039M |
September 30, 2015 | -4.327M |
June 30, 2015 | -4.057M |
March 31, 2015 | -1.993M |
December 31, 2014 | -2.994M |
September 30, 2014 | -2.837M |
June 30, 2014 | -2.057M |
March 31, 2014 | -1.855M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-57.56M
Minimum
Mar 2023
-10.85M
Maximum
Sep 2019
-33.72M
Average
-30.14M
Median
Cash from Operations (Quarterly) Benchmarks
Ligand Pharmaceuticals Inc | 18.73M |
ADMA Biologics Inc | -2.218M |
ACADIA Pharmaceuticals Inc | 29.08M |
Alnylam Pharmaceuticals Inc | -81.52M |
Geron Corp | -62.25M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | 35.03M |
Cash from Financing (Quarterly) | 1.184M |
Free Cash Flow | -209.70M |
Free Cash Flow Per Share (Quarterly) | -0.6295 |
Free Cash Flow Yield | -10.72% |